Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0H8T stock hub

LON/0H8T has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0H8Tis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

505.3M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0H8T

In the news

Latest news · LON/0H8T

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROIC-39

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0H8T market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

139

Groups with data

Currency

USD

Showing 139 of 139 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	73
Employees Change	9%
Employees Change Percent	14.06
Enterprise value	$395.8M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US00461U1051
Last refreshed	2026-05-10
Market cap	$505.3M
Price	$4.8
Price currency	USD
Rev Per Employee	89,244.66x
Sector	Healthcare
Sic	2834
Symbol	lon/0H8T
Website	https://www.aclaristx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.44%
EV Earnings	-7.5x
EV/Sales	64.45x
P/B ratio	6.47x
P/S ratio	79.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-39.3M
Net Income	$-52.8M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-832.58%
Profit Per Employee	$-743,034
Roa5y	-23.63
Roe5y	-61.18
ROIC	-38.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	285.59%
Cagr3y	-18.59%
Cagr5y	-28.34%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	-58.19x
Revenue Growth Q	-85.94x
Revenue Growth Years	0x
Revenue Growth3 Y	-35.93x
Revenue Growth5 Y	3.84x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	$68.7M
Current Assets	$70.6M
Current Liabilities	$21M
Debt	$1.6M
Debt Equity	$0.02
Equity	$78.1M
Net Cash	$113M
Net Cash By Market Cap	$22.37
Net Cash Growth	-25.86%
Net Debt Equity	$-1.45
Tangible Book Value	$78.1M
Tangible Book Value Per Share	$0.65
WACC	7.96

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Working Capital Turnover	$0.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-58.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	285.23%
200-day SMA	2.82
3Y total return	-46.05%
50-day SMA	3.85
50-day SMA vs 200-day SMA	50over200
5Y total return	-81.1%
All Time High	29.8
All Time High Change	-83.91%
All Time High Date	2021-04-07
All Time Low	0.61
All Time Low Change	692.48%
All Time Low Date	2023-11-13
ATR	0.26
Beta	0.68
Ch YTD	60.3
High	4.9
High52	4.9
High52 Date	2026-05-08
High52ch	-2.12%
Low	4.71
Low52	1.17
Low52 Date	2025-05-14
Low52ch	311.68%
Ma50ch	24.54%
Price vs 200-day SMA	69.95%
RSI	68.6
RSI Monthly	56.5
RSI Weekly	71.38
Sharpe ratio	1.6x
Sortino ratio	3.7
Total Return	-58.56%
Tr YTD	60.32
Tr1m	32.31%
Tr1w	8.95%
Tr3m	41.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-59.4M
Operating margin	-938

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	96,690,016%
Shares Insiders	2.26%
Shares Institutions	43.57%
Shares Qo Q	0.04%
Shares Yo Y	58.56%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	5,924.75x
Bv Per Share	0.65
Ch1m	32.31
Ch1w	8.95
Ch1y	285.2
Ch3m	41.48
Ch3y	-46.04
Ch5y	-81.1
Ch6m	115.6
Change	1.4%
Change From Open	0.97
Close	4.73
Days Gap	0.42
Depreciation Amortization	29,340.6
Dollar Volume	6,033.5
Earnings Date	2026-05-14
EBIT	$-59.4M
EPS	$-0.42
F Score	0
Fiscal Year End	December
Founded	2,012
Is Primary Listing	0
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Ma150	3.16
Ma150ch	51.58%
Ma20	4.35
Ma20ch	10.38%
Next Earnings Date	2026-05-14
Open	4.75
Position In Range	45.32
Ppne	2,234,283.6
Price Date	2026-05-08
Ptbv Ratio	6.47
Relative Volume	0.21x
Revenue	6,336,371x
Tr6m	115.56%
Volume	1,258

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0H8T pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0H8T stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0H8T?

Insider, institutional, and short-interest positioning.

Institutional ownership

+43.6%

Share of float held by funds and institutions

Insider ownership

+2.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+58.6%

Negative means the company is buying back shares.

Technical

LON/0H8T momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

68.6

Neutral momentum band

Price vs 200-day MA

+70.0%

50/200-day relationship not available

Beta (5Y)

0.68

Less volatile than the market

Sharpe ratio

1.60

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0H8T

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0H8T stock rating?

lon/0H8T is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0H8T analysis?

The full report lives at /stocks/lon/0H8T/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0H8T?

The latest report frames lon/0H8T around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0H8T page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.